In contrast, knockdown of TNK2-AS1 markedly reduced cell proliferation and promoted apoptosis and differentiation in acute myeloid leukemia cells, suggesting TNK2-AS1 as a potential therapeutic target and prognostic marker for patients with acute myeloid leukemia. This evidence concerns the gene TNK2 and acute myeloid leukemia.